Bcl-2-interacting killer

BIK
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesBIK, BIP1, BP4, NBK, BCL2 interacting killer
External IDsMGI: 1206591 HomoloGene: 924 GeneCards: BIK
Orthologs
SpeciesHumanMouse
Entrez

638

12124

Ensembl

ENSG00000100290

ENSMUSG00000016758

UniProt

Q13323

O70337

RefSeq (mRNA)

NM_001197

NM_007546

RefSeq (protein)

NP_001188
NP_001188.1

NP_031572

Location (UCSC)Chr 22: 43.11 – 43.13 MbChr 15: 83.53 – 83.54 Mb
PubMed search[1][2]
Wikidata
View/Edit HumanView/Edit Mouse

Bcl-2-interacting killer is a protein that in humans is encoded by the BIK gene.[3][4][5]

Function

The protein encoded by this gene is known to interact with cellular and viral survival-promoting proteins, such as BCL2 and the Epstein-Barr virus in order to enhance programmed cell death. Because its activity is suppressed in the presence of survival-promoting proteins, this protein is suggested as a likely target for antiapoptotic proteins. This protein shares a critical BH3 domain with other death-promoting proteins, BAX and BAK.[5]

Interactions

Bcl-2-interacting killer has been shown to interact with BCL2-like 1[6][7][8][9] and Bcl-2.[7][8]

References

  1. "Human PubMed Reference:".
  2. "Mouse PubMed Reference:".
  3. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ (Dec 1995). "Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins". Oncogene. 11 (9): 1921–8. PMID 7478623.
  4. Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP (Dec 1999). "The DNA sequence of human chromosome 22". Nature. 402 (6761): 489–95. PMID 10591208. doi:10.1038/990031.
  5. 1 2 "Entrez Gene: BIK BCL2-interacting killer (apoptosis-inducing)".
  6. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (October 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. PMID 16189514. doi:10.1038/nature04209.
  7. 1 2 Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DC (February 2005). "Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function". Mol. Cell. 17 (3): 393–403. PMID 15694340. doi:10.1016/j.molcel.2004.12.030.
  8. 1 2 Gillissen B, Essmann F, Graupner V, Stärck L, Radetzki S, Dörken B, Schulze-Osthoff K, Daniel PT (July 2003). "Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway". EMBO J. 22 (14): 3580–90. PMC 165613Freely accessible. PMID 12853473. doi:10.1093/emboj/cdg343.
  9. Jiang A, Clark EA (May 2001). "Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis". J. Immunol. 166 (10): 6025–33. PMID 11342619. doi:10.4049/jimmunol.166.10.6025.

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.